跳至主要内容
临床试验/IRCT20220801055597N1
IRCT20220801055597N1招募中3 期

Effects of soy isoflavones on metabolic profile, liver enzymes, hepatic fibrosis, inflammatory markers and total antioxidant capacity in patients with non-alcoholic fatty liver disease, double blind randomized clinical trial

Ahvaz University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • 18-75 years old
  • Willingness to participate in study
  • The concentration of liver enzymes, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) shall be more than 1.5 fold of the maximum normal level.
  • With evidence of non alcoholic fatty liver disease in Fibroscan (CAP score>260)
  • Without a history of alcohol consumption or consuming alcohol less than 10 grams per day in women and less than 20 grams per day in men.
  • Not taking drugs that affect blood lipids, blood sugar and blood pressure, vitamin E and ursodioxycholic acid (UDCA) and hepatotoxic drugs such as phenytoin, amoxifen, lithium, methotrexate, amiodarone, tamoxifen, corticosteroids, valproate, antiviral drugs, etc. ..
  • Without a history of other diseases, chronic and acute liver disorders (hepatitis B, C, etc.), biliary disease, autoimmune diseases, cancer and hereditary disorders affecting the liver (iron or copper storage disease , etc.).
  • Without a history of celiac disease, diabetes, cardiovascular diseases, lung disease, digestive disease affecting food absorption and kidney disease.
  • Without a history of weight loss surgery in the past year or a history of adherence to a weight loss diet in the last 6 months
  • Without a history of thyroid disorder
  • Not taking fiber and soy supplements in the last 3 months
  • Without a history of smoking (cigarettes and other tobacco products)
  • Not regular consumption of soy or soy products in the diet (regular consumption means: consuming more than 30 grams (more than 2 tablespoons) per month)
  • Without a history of liver cirrhosis or not being classified in F4 group

排除标准

  • Pregnancy and breastfeeding
  • History of breast cancer
  • Consuming levothyroxine, warfarin and iron
  • History of allergy to soy and its products

研究者

相似试验

Effect of soy isoflavones in non alcoholic fatty... | 临床试验